DON'T MISS

Bitcoin Snaps Back to $69K in Short Squeeze — Analysts Warn...

0
Bitcoin surged back near $69,000 on Wednesday, rallying more than 10% from Tuesday's low as crypto markets staged a broad relief rally...
Hot Stocks

Oragenics Positions ONP-002 as Potential First-Ever Pharmacological Treatment for Concussion in...

0
Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company developing brain-targeted therapeutics through proprietary intranasal delivery technology, has laid out an ambitious...

CRYPTO NEWS

TECH AND GADGETS

TRENDING

LATEST REVIEWS

Russia Seeks To Limit Anonymous Crypto Deposits

0
The Russian government is putting strict measures to limit anonymous deposits made to online wallets in a move aimed at curbing illicit financial activity....

Hot Of the Press

China Plans To Promote Digital Yuan In The Upcoming 2022 Winter...

0
China continues preparing for the upcoming 2022 Winter Olympic games. The country says it will take advantage of the event to unveil its digital...

STOCK NEWS

Ubisoft Entertainment SA (OTCMKTS: UBSFF) Has Partnered With Tezos to Offer NFTs to PC...

0
Ubisoft Entertainment SA (OTCMKTS: UBSFF) will give Tezos' PC players NFTs starting with the Ghost Recon Breakpoint. Ubisoft joined the NFT platform through its...

Aleph.Im To Participate In Ubisoft’s Entrepreneurs Lab

0
Aleph.Im is set to be one of the participants in the sixth season of Ubisoft’s Entrepreneurs Lab. This blockchain-based storage and computing startup stare...

Beeple Launches We.New To Auction Iconic Moments

0
Mike Winkelmann, a pioneering digital artist & the highest-paid NFT artist known as Beeple, launches we.New. The platform will auction iconic moments in sports,...

JPMorgan Chase (NYSE: JPM) Supposedly Shuts Down a Bitcoin Mining Company’s Bank Account

0
JPMorgan Chase (NYSE: JPM), a banking giant in America, has reportedly blocked Compass Mining's team bank accounts. This Delaware-based Bitcoin mining corporation announced this information...
Hot Stocks

Oragenics Positions ONP-002 as Potential First-Ever Pharmacological Treatment for Concussion in Landmark 2026 Push

0
Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company developing brain-targeted therapeutics through proprietary intranasal delivery technology, has laid out an ambitious...

BUSINESS